Follow-up care over 12 months of patients with prostate cancer in Spain: A multicenter prospective cohort study.
No Thumbnail Available
Identifiers
Date
2021
Authors
Bonfill, Xavier
Martinez-Zapata, María José
Vernooij, Robin Wm
Sánchez, María José
Morales-Suárez-Varela, María
Emparanza, José Ignacio
Ferrer, Montse
Pijoan, José Ignacio
Palou, Joan
Madrid, Eva
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
The therapeutic approach is crucial to prostate cancer prognosis. We describe treatments and outcomes for a Spanish cohort of patients with prostate cancer during the first 12 months after diagnosis and identify the factors that influenced the treatment they received.This multicenter prospective cohort study included patients with prostate cancer followed up for 12 months after diagnosis. Treatment was stratified by factors such as hospital, age group (
Description
MeSH Terms
Aftercare
Aged
Antineoplastic Agents, Hormonal
Brachytherapy
Chemotherapy, Adjuvant
Cohort Studies
Humans
Male
Neoplasm Grading
Prospective Studies
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Spain
Treatment Outcome
Aged
Antineoplastic Agents, Hormonal
Brachytherapy
Chemotherapy, Adjuvant
Cohort Studies
Humans
Male
Neoplasm Grading
Prospective Studies
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Spain
Treatment Outcome